Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 46 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

This paper introduces a novel convolutional neural network model with an attention mechanism to advance Alzheimer disease (AD) classification using Magnetic Resonance Imaging (MRI). The model architecture is meticulously crafted to enhance feature extraction and selectively focus on crucial regions within brain images, thereby improving diagnostic accuracy. A unique component, the MRI Segmentation Block (MSB), is introduced to manage the skull stripping task effectively, highlighting the model ability to learn from complex, multilayered information. We have incorporated a detailed experimental evaluation of the MSB, demonstrating its superior performance in cranial debridement tasks compared to existing methods. The experiments involved a range of MRI scans, assessing the MSB's accuracy through metrics like the Dice Coefficient and Jaccard Index against ground truth annotations by expert radiologists. The results substantiate the MSB's effectiveness, setting a new benchmark for precision in medical imaging diagnostics. The proposed method integrates densely connected neural networks with a connection-wise attention model to extract multiscale features from MRI scans. Furthermore, the attention mechanism is fine-tuned to emphasize salient features significantly associated with various stages of Alzheimer's disease, thereby setting a new benchmark for precision in medical imaging diagnostics. Extensive experiments on the Alzheimer Disease Neuroimaging Initiative (ADNI) dataset demonstrate the superiority of our method over traditional and contemporary approaches, with our model achieving high accuracy and computational efficiency. This makes it suitable for clinical applications where resources are limited. This study represents a significant advancement in the diagnostic process for AD, with potential implications for improving patient outcomes in clinical settings.

Key findings

Why it matters

This study introduces a neural network with an attention mechanism for classifying Alzheimer's disease from MRI scans and reports improved diagnostic accuracy. It is a technical classification study and does not test any treatment, cure, or prevention.

Study details

How this study scored 46/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 5 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 46 of 100.46 of 100 points earned54 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Computers in Biology and Medicine)
Journal's citation record 2 / 4 Computers in Biology and Medicine: journal h-index 189 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 44 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 14.7 citations a year over 3 year(s) since 2025
Impact for its field and year 5 / 6 Cited 28.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 2 / 4 Cited 44 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Young Im Cho: h-index 34 (OpenAlex, whole career)
Institution's track record 0 / 3 Gachon University: institution h-index 253 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40158456)
Free to read 2 / 2 Free to read
Total 46 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Muksimova, S., Umirzakova, S., Iskhakova, N., Khaĭtov, A., & Cho, Y. I. (2025). Advanced convolutional neural network with attention mechanism for Alzheimer's disease classification using MRI. Computers in Biology and Medicine. https://doi.org/10.1016/j.compbiomed.2025.110095

Vancouver

Muksimova S, Umirzakova S, Iskhakova N, Khaĭtov A, Cho YI. Advanced convolutional neural network with attention mechanism for Alzheimer's disease classification using MRI. Computers in Biology and Medicine. 2025. doi:10.1016/j.compbiomed.2025.110095. PMID: 40158456.

BibTeX

@article{muksimova2025-40158456,
  author  = {Muksimova, Shakhnoza and Umirzakova, Sabina and Iskhakova, Nargiza and Khaĭtov, A and Cho, Young Im},
  title   = {{Advanced convolutional neural network with attention mechanism for Alzheimer's disease classification using MRI}},
  journal = {Computers in Biology and Medicine},
  year    = {2025},
  doi     = {10.1016/j.compbiomed.2025.110095},
  pmid    = {40158456},
  url     = {https://doi.org/10.1016/j.compbiomed.2025.110095}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Brain scans and imaging

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →